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Abstract 
 
Mannitol is a frequently used diluent in the production of tablets due to its non-hygroscopic 
character and low drug interaction potential. Although the δ-polymorph of mannitol has 
superior tabletability in comparison to α- and β-mannitol, the latter are most commonly used 
because large-scale production of δ-mannitol is difficult. Therefore, a continuous method for 
production of δ-mannitol was developed in the current study. Spray drying an aqueous solution 
of mannitol and PVP in a ratio of 4:1 resulted in formation of δ-mannitol. The tabletability of a 
physical mixture of spray dried δ-mannitol with PVP (5%) and paracetamol (75%) was clearly 
superior to the tabletability of physical mixtures consisting of spray dried α- and β-mannitol with 
PVP (5%) and paracetamol (75%) which confirmed the excellent tableting properties of the δ-
polymorph. In addition, a coprocessing method was applied to coat paracetamol crystals with 
δ-mannitol and PVP. The tabletability of the resulting coprocessed particles consisting of 5% 
PVP, 20% δ-mannitol and 75% paracetamol reached a maximal tensile strength of 2.1 MPa at 
a main compression pressure of 260 MPa. Moreover the friability of tablets compressed at 184 
MPa was only 0.5%. This was attributed to the excellent compression properties of δ-mannitol 
and the coating of paracetamol crystals with δ-mannitol and PVP during coprocessing. 
 
 
KEYWORDS: Delta mannitol, Spray drying, Coprocessing, Particle coating, Direct 
compression, Paracetamol, Tabletability, Continuous production. 
 
  
List of abbreviations 
d50   Median particle size 
ffc   Flowability index 
MCP   Main compression pressure 
MDSC   Modulated differential scanning calorimetry 
PC   Principal component 
PCA   Principal component analysis 
PVP   Polyvinylpyrrolidone 
SEM   Scanning electron microscopy 
To   Outlet temperature 
TS   Tensile strength 
XRD   X-ray diffraction 
 
  
1. Introduction 
 
Tablets are the most commonly used dosage form, accounting for 70-80% of all 
pharmaceutical preparations, due to their ease of manufacturing, accurate dosing 
and high patient compliance [1, 2]. 
Mannitol is an acyclic sugar often used as tablet diluent in the neutraceutical 
and pharmaceutical industry [3]. The major advantages of mannitol over other 
excipients are its non-hygroscopic character, which makes it an excipient of choice 
for moisture sensitive drugs, and its low drug interaction potential [4, 5, 6]. Mannitol 
is also frequently used in chewable and orodispersible tablets due to its sweetness, 
cooling mouth sensation, high solubility and fast disintegration in water [3, 4, 6]. 
Especially with pediatric and geriatric patients, rapidly disintegrating and dispersing 
tablets can add to the patients’ compliance as it overcomes swallowing problems. 
Additionally, mannitol is used as a bulking agent in lyophilizates due to its ability to 
form solid, elegant cakes in the vials [4, 7]. 
Three polymorphs, α-, β- and δ-mannitol, and mannitol hemi-hydrate, a pseudo-
polymorphic form formed during freeze-drying, have been described in literature [8]. 
Burger et al. evaluated the compaction properties of these three polymorphs since 
the crystallographic and thermodynamic properties of polymorphs vary which can 
affect their compaction behavior [8]. They reported on superior compressibility and 
tabletability of the δ-polymorph in comparison to the α- and β-polymorphs of 
mannitol. More recently, Wagner et al. confirmed this result as they found an 
improved tabletability of δ-mannitol granules after roller compaction [3]. 
Several crystallization reactions are reported for the production of δ-mannitol [8, 
9, 10, 11]. However, reproducible and scalable production of δ-mannitol by 
crystallization is difficult [8]. δ-mannitol was also obtained during cospray drying of 
aqueous solutions of mannitol and trypsin in different ratios [12]. However, a 
coprocessed excipient including a protease is not preferred. As a result, 
commercially available mannitol grades consist almost exclusively of α- or β-
mannitol or a mixture thereof. Therefore, it was the first aim to develop a continuous 
manufacturing method for the production of δ-mannitol via spray drying. Aqueous 
solutions of mannitol and polyvinylpyrrolidone (PVP) were spray dried at two outlet 
drying temperatures and the polymorphic content and tabletability of these spray 
dried samples were evaluated.  
The second part of the study evaluated if coprocessing of paracetamol with δ-
mannitol and PVP could overcome the poor tabletability of paracetamol in a single 
processing step. Coprocessing of excipients is widely practiced for the production of 
directly compressible excipients: e.g. Cellactose® (microcrystalline cellulose and 
lactose), Ludipress® (lactose, PVP and crospovidone), StarLac® (lactose and maize 
starch), Avicel® CE (microcrystalline cellulose and guar gum) [1]. Cospray drying of 
excipients and active pharmaceutical ingredients has also been successfully applied 
to generate agglomerates with a unique particle size and shape and 
physicochemical properties [13]. In the current study, a coprocessing method 
recently described by Vanhoorne et al. was applied for the production of a 
coprocessed mixture consisting of 5% PVP, 20% δ-mannitol, and 75% paracetamol 
[14]. The morphology, solid state and particle size distribution of the coprocessed 
sample was evaluated and its compression properties were compared to a physical 
mixture.    
 
2. Materials and methods 
 
2.1. Materials 
 
α-mannitol (Pearlitol 200) and β-mannitol (C*PharmMannidex) were kindly 
donated by Cargill (Vilvoorde, Belgium). δ-mannitol (Parteck Delta) was kindly 
donated by Merck (Darmstadt, Germany). These mannitol samples were used as 
reference material. β-mannitol was used for the preparation of the spray dried 
solutions. Paracetamol (semi-fine) was received from Mallinckrodt Chemical 
(Hazelwood, USA). Magnesium stearate and silicon dioxide (Fagron, Waregem, 
Belgium) were used as lubricant and glidant, respectively. PVP (Kollidon 30) and 
crospovidon (Kollidon CR) were received from BASF (Burgbernheim, Germany). 
Miglyol 812 (Cremer Oleo, Witten, Germany) with 0.2% polysorbate 80 (Fagron, 
Waregem, Belgium) was used as dispersant for laser diffraction measurements. 
 
2.2. Methods 
 
2.2.1. Spray drying and coprocessing 
 
In preliminary spray drying experiments, an 18% w/w aqueous solution of 
mannitol and PVP (ratio mannitol:PVP: 4:1) and an 18% w/w aqueous solution of 
pure mannitol were spray dried (F1 and F2, respectively) on a lab-scale spray dryer 
(B290, Büchi Labortechnik, Flawil, Switzerland) equipped with a two-fluid nozzle 
(nozzle orifice 1.4 mm). The spray dried samples were collected after the cyclone. 
The solutions were spray dried at a constant feed rate of 16 g/min and an 
atomization pressure of 50%. The inlet and outlet drying air temperature were 220 
and 80 °C, respectively.  
In the main spray drying experiments, 18% w/w aqueous solutions of mannitol 
and PVP (mannitol:PVP ratios of 9:1 and 4:1) and an 18% w/w aqueous solution of 
pure mannitol were spray dried on a pilot-scale spray dryer (Mobile Minor, GEA 
Niro, Copenhagen, Denmark) equipped with a two-fluid nozzle (nozzle orifice 2.0 
mm). The solutions were transferred to the spray dryer by a peristaltic pump (520U, 
Watson Marlow, Cornwall, UK) with marprene tubing (inside diameter 4.8 mm). The 
spray dryer was operated in co-current mode. The dimensions of the drying 
chamber were 0.84 m cylindrical height with a diameter of 0.80 m and 60° conical 
base. The solutions were spray dried at a constant feed rate of 45 g/min and an 
atomizing air pressure of 1 bar. The inlet drying air temperature was varied between 
170 and 220 °C, resulting in outlet temperatures of 60 and 80 °C, respectively.  
An overview of the spray dried solutions (F1-3) on the lab-scale and pilot-scale 
spray dryers and the composition of the resulting solid samples is given in Table 1. 
The yield (%) of the spray drying process was defined as the weight fraction of the 
material recovered from the collecting reservoir after spray drying in relation to the 
amount of mannitol and PVP originally contained in the atomized liquid feed. 
In a second part of the study, paracetamol crystals were coated with mannitol 
and with mannitol and PVP via a coprocessing method proposed by Vanhoorne et 
al. in order to improve the tabletability of paracetamol crystals [Vanhoorne]. A 
detailed description of the method and schematic setup was given by Vanhoorne 
et al. [14]. Hence, 18% w/w aqueous solutions of pure mannitol and of mannitol and 
PVP (mannitol:PVP ratio: 4:1) were fed to the fountain two-fluid nozzle (nozzle 
orifice 2.6 mm) of a production-scale spray dryer (type 6.3-SD, GEA Niro, 
Copenhagen, Denmark) by a peristaltic pump (520U, Watson Marlow, Cornwall, 
UK) and marprene tubing (inside diameter 4.8 mm). The spray dryer operated in 
counter-current mode. The dimensions of the spray dryer were 2.0 m cylindrical 
height with a diameter of 3.5 m and 60° conical base. The spray dried powder was 
collected in a reservoir under the drying chamber. The solutions were spray dried 
according to the following parameters: feed rate: 100 g/min, inlet drying air 
temperature: 240 °C, outlet drying air temperature: 112 °C, atomizing air pressure 
0.5 bar. Paracetamol crystals were preblended with 0.05% silicon dioxide and 
introduced during the spray drying process at a feed rate of 48 g/min into the cone 
of the spray dryer via an in-house designed setup described by Vanhoorne et al. 
[14]. Using this setup, the paracetamol crystals were directly injected into the spray 
of atomized drops in the drying chamber of the spray dryer. The composition of the 
spray dried solutions and final composition of the coprocessed powders (F4 and 
F5) is included in Table 1. 
 
2.2.2. Preparation of physical mixtures 
 
Physical mixtures (PM1-4) were prepared in a tumbling blender (Turbula mixer 
type T2F, W.A. Bachofen Maschinenfabrik, Basel, Switzerland) for 10 min at 49 
rpm to evaluate the influence of PVP and the added value of coprocessing via spray 
drying on tabletability. An overview of the prepared physical mixtures is listed in 
Table 2. 
 
2.2.3. Tableting 
 
The spray dried and coprocessed powders and physical mixtures were blended 
(Turbula mixer type T2F, W.A. Bachofen Maschinenfabrik, Basel, Switzerland) for 
5 min at 49 rpm with 5% crospovidon® and 0.5% magnesium stearate prior 
tableting. 
Tablets (500 mg ± 10 mg) of the spray dried and coprocessed powders (F1-5) 
and physical mixtures (PM1-4) were compressed on a rotary tablet press (ModulTM 
P, GEA Courtoy, Halle, Belgium) equipped with a single round concave Euro B 
punch of 12 mm diameter at a tableting speed of 5 rpm. The tablets were 
compressed at 6 different compaction pressures: 34 (± 8), 61 (±9), 100 (±11), 143 
(±10), 184 (±5) and 229 (±9) MPa. 
 
2.2.4. Material characterization  
 
2.2.4.1. Morphology 
 
The powders were examined by scanning electron microscopy (SEM) (JEOL 
JSM-5600-LV, JEOL Ltd., Zaventem, Belgium) after sputtering with a platinum 
coating using the JEOL JFC 1300 Autofine Coater (JEOL, Zaventem, Belgium) to 
improve the electron conductivity of the samples. 
  
  
2.2.4.2. Karl Fischer titration 
 
To determine the residual moisture content, Karl Fischer titrations (Mettler 
DL35, Mettler Toledo, Zaventem, Belgium) were performed (n=3) on the powder 
samples immediately after production. Powder (100–200 mg) was added to an 
airtight beaker containing absolute dry methanol (Biosolve, Valkenswaard, the 
Netherlands). Titration of the samples was performed using Karl Fischer reagent 
(Hydranal_Composite 2, Sigma–Aldrich, Munich, Germany). The mixture was stirred 
for 5 min before actual titration.  
 
2.2.4.3. Particle size analysis 
 
The particle size distribution of the paracetamol starting material, spray dried 
and coprocessed powders was measured in triplicate by laser diffraction 
(Mastersizer S long bench, Malvern Instruments, Worcestershire, UK) and the 
average particle size distribution was calculated via the Mastersizer 2000 software. 
The wet dispersion technique was applied using the 300RF lens (Malvern 
Instruments, Worcestershire, UK). The powders were dispersed in a solution of 0.2% 
Tween 80 in Miglyol 812 and subsequently vortexed and sonicated in order to 
eliminate agglomerates. The results are expressed as volume diameters. 
 
2.2.4.4. Ring shear testing 
 
The flowability expressed as the flowability index (ffc) of the powders was 
measured in triplicate by ring shear testing (Type RST-XS, Dietmar Schulze 
Schüttgutmesstechnik, Wolfenbuttel, Germany). The powders were tested using a 
preshear of 1000 Pa at three consolidation stresses, 400, 600 and 800 Pa. 
 
2.2.4.5. Solid state characterization 
 
The polymorphic mannitol composition in the spray dried and coprocessed 
samples was analyzed using Raman spectroscopy, X-ray diffraction (XRD) and 
modulated differential scanning calorimetry (MDSC). 
Raman spectra (Raman Rxn1, Kaiser Optical Systems, Ann Arbor, United 
States) of the samples were recorded (n=8) using exposure times of 10 s with 3 
accumulations. All spectra were recorded with a resolution of 4 cm-1. The spectral 
region between 1000 and 1200 cm-1 was selected for evaluation of mannitol 
polymorphism. Spectra were centered and SNV-correction was applied to correct 
for the physical variation between measurements. The spectra were used for 
identification of the polymorphic forms present in the formulation and therefore the 
spectra were compared with the spectra of reference material of α-, β- and δ-
mannitol. Additionally, principal component analysis (PCA) was executed on the 
spectra of the pilot-scale spray dried samples with Simca 13.0.3 software (Umetrics, 
Umeå, Sweden). To investigate the stability of the pilot-scale spray dried samples, 
they were stored 6 months at 60% relative humidity and 25 °C and reanalyzed by 
Raman spectroscopy as described above. 
XRD analysis of the samples and mannitol references was performed on a 
CuKα diffractor (ARLTM X’TRA, Thermo Fischer Scientific, Waltham, United States) 
with a voltage of 40 mV in the angular range of 5°<2θ<60° using a step scan mode 
with step size of 0.02° and counting time of 1s/step.  
MDSC was performed using a Q2000 differential scanning calorimeter (TA 
Instruments, Zellik, Belgium) equipped with a refrigerated cooling system. Samples 
(5–10 mg) were accurately weighed and run in Tzero pans (TA Instruments, Zellik, 
Belgium). They were cooled to -20 °C and subsequently heated up to 220 °C with a 
heating rate of 2 °C/min. The modulation time and amplitude were set at 60 s and 
0.318 °C, respectively. Dry nitrogen was used as a purge gas through the cell at a 
flow rate of 50 ml/min. The results were analyzed using TA Instruments Universal 
Analysis software. 
 
2.2.5. Tablet characterization 
 
The hardness, thickness and diameter of the tablets (n=10) were determined 
using a hardness tester (Type HT 10, Sotax, Basel, Switzerland) and the tensile 
strength (TS) of the tablets was calculated according to the formula of Fell and 
Newton [15]: 
TS = 2F/πdt 
Where F, d and t denote the diametral crushing force, tablet diameter and tablet 
thickness, respectively.  
The friability of tablets compressed at 184 (±5) MPa was determined using a 
friabilator (PTFE, Pharma Test, Hainburg, Germany) as described in the European 
Pharmacopea at a speed of 25 rpm for 4 min. The percentage weight loss was 
expressed as the tablet friability.  
 
3. Results and discussion 
 
3.1. Influence of PVP inclusion and outlet temperature on the formation of δ-
mannitol 
 
In preliminary experiments spray dried mannitol samples without PVP (F1) and 
with 20% PVP (F3) were prepared on a lab-scale spray dryer. Identification of the 
mannitol polymorphs in the samples was performed by Raman spectroscopy, XRD 
and MDSC through comparison with reference material of α-, β- and δ-mannitol. 
Raman spectroscopy (Figure 1) and XRD (Figure 2) identified a mixture of α- and β-
mannitol in the sample without PVP and δ-mannitol the sample with 20% PVP, 
respectively. MDSC analysis of the samples proved not to be helpful for the 
identification of different mannitol polymorphs since a melting peak at 166 – 167 °C 
with identical melting enthalpy was detected for reference material of α-, β- and δ-
mannitol. Not uniform melting of δ-mannitol at 155 °C followed by crystallisation to 
α- or β-mannitol and melting of the respective crystal form or mixture is nevertheless 
reported in literature [8, 16].  
Formulations F1-3 (Table 1), containing different PVP concentrations in the final 
spray dried powder, were spray dried on a pilot-scale spray dryer at 2 different outlet 
temperatures (To): 60 and 80 °C. The influence of the PVP content and the outlet 
temperature on the mannitol polymorph formed during spray drying was qualitatively 
evaluated by Raman spectroscopy. The results of the Raman analysis were 
summarized in a PC1 versus PC2 scores plot of the first and second principal 
component (PC), explaining 83% and 15% of the variation in the dataset, 
respectively (Figure 3). Analysis of the loading plots (Figure 4) of the PC learned 
that the first PC was selective for the presence of δ-mannitol whereas the second 
PC could differentiate between α- and β-mannitol. Three clusters of samples around 
the data points of the α-, β- and δ-mannitol reference materials could be 
differentiated on the PC1 versus PC2 scores plot. Independently of the applied outlet 
temperature, the spray dried samples containing 0% and 10% PVP consisted of 
exclusively β- and α-mannitol, respectively. Inclusion of 20% PVP in the formulation 
(F3) yielded powders consisting of mainly δ-mannitol but traces of α-mannitol were 
also detected. The polymorphic content in these samples was dependent on the 
outlet temperature used. Applying an outlet temperature of 60 °C resulted in a spray 
dried sample with exclusively δ-mannitol next to PVP whereas traces of α-mannitol 
were still present in the sample spray dried at an outlet temperature of 80 °C. These 
results were confirmed by XRD (Figure 5) as characteristic peaks of β-mannitol 
(10.56°, 14.71°), α-mannitol (13.79°) and δ-mannitol (9.57°) were detected in 
samples F1, F2 and F3, respectively. [5, 6, 7, 8, 17, 18]. 
The yields of the spray drying experiments and residual moisture content of the 
resulting samples are listed in Table 3. The process yield varied between 23 and 
89%, depending on the percentage of PVP in the formulation and the outlet 
temperature used. Inclusion of PVP decreased the process yield due to the sticky 
nature of PVP and its high hygroscopicity which is also reflected in the high residual 
moisture content of the samples with 20% PVP [4]. Increasing the outlet temperature 
positively influenced the yield as the particles were drier and therefore less sticky 
before they hit the dryer wall.  
Spray drying of a pure mannitol solution resulted in small agglomerates 
composed of spherical particles (Figure 6). Addition of PVP to the spray dried 
mannitol solution yielded larger coalesced particles where individual particles were 
more difficult to distinguish. 
The particle size distribution and median particle size (d50) of spray dried 
samples F1-3 is shown in Figure 7. Inclusion of PVP in the formulation resulted in 
particles with a higher d50 value since PVP acted as a binder favoring agglomeration 
during the spray drying process. However, increasing the PVP content from 10 to 
20% in the final spray dried samples had no effect on d50. The larger d50 of F2 and 
F3 was reflected in their flowability as they were classified as easy-flowing (despite 
the higher moisture content of these samples), whereas F1 was classified as very 
cohesive based on the ffc values. Thus, inclusion of PVP in the formulation to form 
δ-mannitol during spray drying also proved to be an asset with regard to flowability.  
Compression profiles of the spray dried samples were constructed for 
evaluation of the tabletability of the different mannitol polymorphs (Figure 8, full 
lines). The spray dried sample with δ-mannitol (F3) clearly exhibited superior 
tabletability in comparison to the samples with the α- and β-polymorphs (F1, F2), 
reaching a maximum TS of 6.2 (±0.3) MPa at a main compression pressure (MCP) 
of 184 (±5) MPa. Note that the PVP content of these samples was different. To 
exclude the effect (a plastically deforming binder under compression) paracetamol 
formulations containing the different spray dried mannitol samples with a constant 
(5%) PVP content (PM1-3 in Table 2) were processed into tablets (depending on the 
formulation part of PVP was included in the spray dried material and/or added as 
such to the physical mixture). Their tabletability is also included in Figure 8 (dotted 
lines). Obviously the tabletability of these formulations is lower compared to the 
spray dried samples due to the high load (75%) of paracetamol, a model drug known 
for its poor tabletability. However, the tabletability of the formulation containing δ-
mannitol (PM3) was significantly higher than of the physical mixtures with α- and β-
mannitol (PM1 and PM2), which was linked to the superior tabletability of δ-mannitol. 
This confirmed the findings of Burger et al. and Wagner et al. [3, 8]. 
The excellent tabletability of spray dried δ-mannitol and PVP was also reflected 
in the friability of the tablets. While the friability of tablets composed of spray dried 
samples was below 0.1% (independently of their polymorphic content or the 
percentage PVP), the inclusion of paracetamol in the physical mixtures resulted in 
a friability of 6.4%, 6.4% and 3.0% for PM1, 2 and 3, respectively.  
  
3.2. Tabletability of coprocessed samples  
 
Since production of δ-mannitol in a continuous way via spray drying was 
possible, it was next investigated whether paracetamol and δ-mannitol could be 
coprocessed in a single step, using the method proposed by Vanhoorne et al. [14]. 
Paracetamol crystals were injected into a spray of atomized drops during the spray 
drying process. An aqueous solution of 18.0% w/w mannitol (F4) and an aqueous 
solution of mannitol and PVP (F5) were spray dried (Table 2). The ratio of mannitol 
to PVP in F5 was 4:1 which is equal to the ratio used in the spray drying experiments 
(F3) yielding δ-mannitol.  
The polymorphic state of mannitol in the coprocessed samples was investigated 
by XRD and Raman spectroscopy. Identification of the mannitol polymorphs by XRD 
was not possible due to the presence of 75% paracetamol, dominating the spectrum. 
Raman analysis revealed the presence of β-mannitol in coprocessed sample F4. 
However, δ-mannitol could not be detected in coprocessed sample F5 via Raman 
spectroscopy due to the dominant influence of paracetamol on the spectrum. Since 
it was proven in the first part of the study that spray drying mannitol and PVP in a 
ratio of 4:1 yielded δ-mannitol on both a lab scale and pilot scale spray dryer 
irrespectively of the applied outlet temperature, the presence of δ-mannitol in sample 
F5 was assumed. 
The morphology of the coprocessed samples was evaluated by SEM and is 
shown in Figure 9. In this case no spherical particles were obtained since irregular-
shaped paracetamol crystals were introduced in the spray of atomized drops, and 
their shape dominated in the collected spray dried powder. More agglomerated 
particles were observed in sample F5 which was attributed to PVP acting as a 
binder. This was confirmed by laser diffraction analysis of the samples (Figure 10): 
d50 of samples F4 and F5 were 108.2 µm and 230.9 µm, respectively, exceeding the 
d50 of paracetamol starting material (44.4 µm). Thus in both experiments 
agglomeration occurred, however, inclusion of PVP in F5 favored agglomeration. 
Despite the significant difference in particle size of the coprocessed samples, both 
were classified as cohesive based on their ffc value (which is linked to their irregular 
shape).  
The tabletability of the coprocessed samples (F4 and F5) was compared to the 
tabletability of physical mixtures (PM3 and PM4) with the same composition (Figure 
11). The tabletability of coprocessed sample F4 was slightly but significantly better 
than of its physical mixture PM4. In contrast, the tabletability of coprocessed sample 
F5 was clearly superior to the tabletability of physical mixture PM3: the TS of PM3 
tablets was 0.9 MPa at a MCP of 300 MPa, whereas F5 tablets yielded a TS of 2.1 
MPa. This demonstrated the added value of the applied coprocessing method which 
is due to the coating of paracetamol crystals with δ-mannitol and PVP.  
While the tablet friability of coprocessed sample F4 (30.5%) and the 
corresponding physical mixture PM4 (46.8%), which contained 25% β-mannitol and 
75% paracetamol, was too high, the friability of the coprocessed sample F5, 
formulated with 5% PVP, 20% δ-mannitol and 5% paracetamol was excellent (0.5%) 
and considerably lower than of the corresponding physical mixture PM3 (3.0%) 
which again illustrated the added value of the coprocessing method.  
 
3.3. Stability of the spray dried samples 
 
It is well known that thermodynamically unstable polymorphs can convert over 
time to a more stable crystal form. As the δ-polymorph is not the thermodynamically 
stable crystal form of mannitol at ambient conditions, the physical stability of the 
spray dried samples (F1-3) stored at 60% relative humidity and 25 °C during 6 
months was investigated by Raman spectroscopy [8]. No spectral differences were 
detected after storage which indicated stability of all mannitol polymorphs over at 
least 6 months. Kinetic stability of α- and δ-mannitol was also proven by Burger et 
al. during mechanical stress and storage for over five years at 25 °C at a relative 
humidity of 43% [8]. 
 
4. Conclusions 
 
Spray drying an aqueous solution of mannitol and PVP (mannitol:PVP: 4:1) 
resulted in formation of δ-mannitol which exhibited excellent tabletability and friability 
in comparison to α- and β-mannitol. Inclusion of PVP in the spray dried mannitol 
solution positively influenced the flowability since the resulting agglomerates were 
larger.  
Additionally, a coprocessing method was applied for the production of δ-
mannitol in a continuous way by spray drying aqueous solutions of mannitol and 
PVP and to agglomerate these particles with paracetamol crystals in the same 
process. The tabletability and friability of the resulting particles was excellent which 
was attributed to the superior tabletability of δ-mannitol over α- and β-mannitol and 
to the application of the coprocessing method which enabled coating of paracetamol 
crystals with δ-mannitol and PVP.  
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Table 1: Overview of the spray dried solutions and composition of the final spray dried 
and coprocessed samples. 
 
 
Composition 
of spray dried 
solutions (% 
w/w) 
Feed rate 
solid 
particle 
introduction 
(g/min) 
Final composition of spray 
dried sample (% w/w) 
Spray dryer 
 PVP mannitol  PVP mannitol paracetamol  
F1 0 18.0 - 0 100 - 
lab-scale + 
pilot-plant 
F2 1.8 16.2 - 10 90 - pilot-plant 
F3 3.6 14.4 - 20 80 - 
lab-scale + 
pilot-plant 
F4 0 16.0 48 0 25 75 
production-
scale 
F5 3.2 12.8 48 5 20 75 
production-
scale 
  
Table 2: Overview of the prepared physical mixtures.  
 
 SD 
sample (% 
w/w) 
Paracetamol 
(% w/w) 
PVP  
(% w/w) 
PM1 20.0 (F1) 75.0 5.0 
PM2 22.5 (F2) 75.0 2.5 
PM3 25.0 (F3) 75.0 - 
PM4 25.0 (F1) 75.0 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 3 Overview of the yield and residual moisture (±SD) content of the spray drying 
experiments performed on the pilot-scale spray dryer. 
 
Outlet 
temperatur
e (°C) 
Formulatio
n 
Yiel
d 
(%) 
Moisture 
content (%) 
60 
F1 70 0.16 (± 0.05) 
F2 54 3.10 (± 0.10) 
F3 23 5.50 (± 0.10) 
80 
F1 89 0.63 (± 0.07) 
F2 66 2.56 (± 0.09) 
F3 59 5.19 (± 0.10) 
 
  
Figures 
 
Figure 1 Raman spectra of α-, β- and δ-mannitol reference material and samples F1 and 
F3 spray dried on a lab-scale spray dryer. 
 
Figure 2 XRD spectra of α-, β- and δ-mannitol reference material and samples F1 and 
F3 spray dried on a lab-scale spray dryer. 
 
Figure 3 PCA score plot of PC1 vs PC2 obtained after PCA analysis on all spray dried 
samples (To 60 °C and 80 °C) and reference material of α-, β- and δ-mannitol. 
 
Figure 4 Raman spectra of α-, β- and δ-mannitol reference material and loadings of PC1 
and PC2 obtained after PCA analysis. 
 
Figure 5 XRD patterns of α-, β- and δ-mannitol reference material and samples F1-3 
spray dried at To 80°C and 60°C. 
 
Figure 6  SEM images of spray dried samples F1-3. 
 
Figure 7 Particle size distribution of samples F1, F2 and F3 spray dried at an outlet 
temperature of 80°C. 
 
Figure 8 Tabletability of the spray dried powders (F1-3) and physical mixtures (PM1-3). 
 
Figure 9 SEM images of coprocessed samples F4 and F5. 
 
Figure 10 Particle size distribution of paracetamol starting material and coprocessed 
samples F4 and F5. 
 
Figure 11 Tabletability of coprocessed samples F4 and F5 and corresponding physical 
mixtures PM4 and PM3. 
 
Figure 1 Raman spectra of α-, β- and δ-mannitol reference material and samples F1 and 
F3 spray dried on a lab-scale spray dryer. 
 
Figure 2 XRD spectra of α-, β- and δ-mannitol reference material and samples F1 and 
F3 spray dried on a lab-scale spray dryer. 
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Figure 3 PC1 versus PC2 scores plot obtained after PCA of all pilot-scale spray dried 
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Figure 4 Raman spectra of α-, β- and δ-mannitol reference material and loadings of PC1 
and PC2 obtained after PCA analysis. 
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Figure 5 XRD patterns of α-, β- and δ-mannitol reference material and samples F1-3 
spray dried at To 80 °C and 60 °C. 
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Figure 6  SEM images of spray dried samples F1-3. 
 
 
 
Figure 7 Particle size distribution of samples F1, F2 and F3 spray dried at an outlet 
temperature of 80°C. 
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Figure 8 Tabletability of the spray dried powders (F1-3) and physical mixtures (PM1-3). 
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Figure 9 SEM images of coprocessed samples F4 and F5. 
 
Figure 10 Particle size distribution of paracetamol starting material and coprocessed 
samples F4 and F5. 
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Figure 11 Tabletability of coprocessed samples F4 and F5 and corresponding physical 
mixtures PM4 and PM3. 10 
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